XTL Biopharmaceuticals Ltd. (XTLB) - NASDAQ
Company Description
XTL Biopharmaceuticals Ltd engages in the acquisition and development of proprietary products and late-stage pharmaceutical products for the treatment of unmet clinical needs. It has three product candidates in clinical development: the hCDR1 peptide for the treatment of Systemic Lupus... More
Sector: Healthcare
Industry: Biotechnology
Country: Israel